Novel Stent-Based Clot Retriever Offers Integrated Protection

This integration of a protection device directly onto the stent retriever reduces the number of devices needed in thrombectomy procedures, and prevents clot fragmentation or embolism during retrieval, reducing the risk for secondary stroke during these procedures.

In Europe alone, approximately two million people suffer strokes each year, 78% of which are ischemic strokes, caused by a dislodged blood clot or arterial plaque debris traveling to the brain and blocking a cerebral artery. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment with the ReCover. The ReCover Thrombectomy Device is a product of Lazarus Effect (Campbell, CA, USA), and has received the European Community CE marking of approval.

“The Lazarus ReCover is a significant advancement in the stent-based retriever category,” said Martin Dieck, chairman and CEO of Lazarus Effect. “By integrating protection directly onto the proven stent retriever design, Lazarus Effect has reduced the number of devices that may be needed for the procedure, decreasing complexity and saving critical time while simultaneously creating a device that should be more effective at preventing thrombus loss during removal.”

Related Links:
Lazarus Effect